A rare case of squamous cell carcinoma lung with multiple locoregional recurrences and histological transformation

A 52-year-old female nonsmoker with localized squamous cell carcinoma (T3N1M0) of lung underwent lobectomy with adjuvant chemotherapy. Two years later, the patient had her first locoregional recurrence with adenosquamous cell carcinoma, and pneumonectomy with adjuvant chemotherapy rendered her disease free. Subsequent isolated locoregional recurrence with squamous cell carcinoma 18 months later was treated with chemoradiotherapy and had a complete response. Patient yet again had locoregional recurrence after 4 years and had progressive disease despite subsequent multiple line of treatment with platinum-based chemotherapy, stereotactic body radiation therapy, and nivolumab. This case is unique in presentation due to prolonged survival with multiple line of treatment of recurrent locoregional tumor without distant metastasis and alteration in the histology of tumor during illness.

[1]  J. Ahn,et al.  Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases , 2016, Journal of pathology and translational medicine.

[2]  G. Scagliotti,et al.  Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study , 2016, Targeted Oncology.

[3]  P. V. Van Schil,et al.  Optimising treatment for post-operative lung cancer recurrence , 2016, European Respiratory Journal.

[4]  J. Zhao,et al.  Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature , 2016, Medicine.

[5]  C. Rudin,et al.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[6]  L. Sequist,et al.  Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. , 2015, The Lancet. Oncology.

[7]  G. Nicholas,et al.  Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysis. , 2013, Clinical lung cancer.

[8]  K. Shimizu,et al.  Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy. , 2013, Interactive cardiovascular and thoracic surgery.

[9]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. , 2010, International journal of radiation oncology, biology, physics.

[10]  P. Dartevelle,et al.  Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. , 2008, The Annals of thoracic surgery.

[11]  P. Pairolero,et al.  Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. , 2007, The Annals of thoracic surgery.

[12]  R. Tsuchiya,et al.  Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  Y. Ichinose,et al.  Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment. , 1994, The Journal of thoracic and cardiovascular surgery.